Trial intelligence / Profile preview

Compression therapy with surgical gloves and stockings for prevention of docetaxel-induced peripheral neuropathy

jRCTs062200061Recruiting

Start
Apr 2021
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of docetaxel in prostate cancer (PCa). Primary endpoint: peripheral neuropathy. Started Apr 2021; status: recruiting.

02

Drugs

docetaxel
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on jRCTs062200061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs062200061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call